TRELEGY ELLIPTA pdr inh 92/55/22mcg 30 dos
7680668080014
CH-66808
R03AL08
03.99.0.
Reimbursement limitations:
TRELEGY
Pour les patients atteints de BPCO modérée après ≥ 1 exacerbation, qui sont insuffisamment traités …
1 / 3
google
Details
- Product number
- 6680801
- CPT
- -
- Packaging group
- 30
- Unit
- Einzeldose(n)
- Composition
- fluticasoni furoas 100 µg, umeclidinium 62.5 µg ut umeclidinii bromidum, vilanterolum 25 µg ut vilanteroli trifenatas, excipiens ad pulverem pro dosi.
Articles (1)
Trelegy Ellipta, Einzeldosiertes Pulver zur Inhalation
Einzeldosiertes Pulver zur Inhalation
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
92.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
55.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
65.3 UG | Substance | WIZUS |
|
(N/A)
|
22.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 87.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2019
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 66808
- Drug name
- Trelegy Ellipta, Einzeldosiertes Pulver zur Inhalation
- Galenic form
- PULIN
- ATC Code
- R03AL08
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 20/09/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 03.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TRELEGY ELLIPTA pdr inh 92/55/22mcg 30 dos
- Description (DE)
- TRELEGY ELLIPTA Inh Plv 92/55/22mcg 30 Dos
- Market launch
- 20/09/2018
- Narcotic (BTM)
- No